End-stage liver disease without hemochromatosis associated with elevated hepatic iron index

Journal of Hepatology

Volumn 29, Issue 2, 1998, Pages 257-262

  Cotler, Scott J ^a   Bronner, Mary P ^a   Press, Richard D ^b   Carlson, Timothy H ^a   Perkins, James D ^c   Emond, Mary J ^a   Kowdley, Kris V ^a,c  

^a UNIVERSITY OF WASHINGTON   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Hepatic iron index; HLA H; Liver transplantation

Indexed keywords

ALCOHOL; AMINO ACID; ASPARTIC ACID; CYSTEINE; FERRITIN; HISTIDINE; IRON; TYROSINE;

ADULT; ALCOHOL LIVER CIRRHOSIS; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; EXPLANT; FEMALE; GENOTYPE; HEMOCHROMATOSIS; HEPATITIS C; HUMAN; HUMAN TISSUE; IRON BINDING CAPACITY; LIVER CIRRHOSIS; LIVER FAILURE; LIVER LEVEL; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; POINT MUTATION; PRIORITY JOURNAL;

EID: 0032147154     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(98)80011-1     Document Type: Article

References (36)

1. Edwards CQ, Griffen LM, Goldgar D, Drummond C, Skolnick MH, Kushner JP. Prevalence of hemochromatosis among 11,065 presumably healthy blood donors. N Engl J Med. 318:1988;1355-1362.
2. Adams PC, Valberg LS. Evolving expression of hereditary hemochromatosis. Semin Liver Dis. 16:1996;47-54.
3. Kilpe VE, Krakauer H, Wren RE. An analysis of liver transplant experience from 37 transplant centers as reported to medicare. Transplantation. 56:1993;554-561.
4. Farrell FJ, Nguyen M, Woodley S, Imperial JC, Garcia-Kennedy R, Man K, et al. Outcome of liver transplantation in patients with hemochromatosis. Hepatology. 20:1994;404-410.
5. Kowdley KV, Hassanein T, Kaur S, Farrell FJ, Van Thiel DH, Keeffe EB, et al. Primary liver cancer anc survival in patients undergoing liver transplantation for hemochromatosis. Liver Transplant Surg. 1:1995;237-241.
6. Pillay P, Tzoracoleftherakis E, Tzakis AG, Kakizoe S, Van Thiel DH, Starzl TE. Orthotopic liver transplantation for hemochromatosis. Transplant Proc. 23:1991;1888-1889.
7. Poulos JE, Bacon BR. Liver transplantation for hereditary hemochromatosis. Dig Dis. 14:1996;316-322.
8. Valberg LS, Ghent CN, Lloyd DA, Frei JV, Chamberlain MJ. Diagnostic efficacy of tests for the detection of iron overload in chronic liver disease. Can Med Assoc J. 119:1978;229-236.
9. Dadone MM, Kushner JP, Edwards CQ, Bishop DT, Skolnick MH. Hereditary hemochromatosis: analysis of laboratory expression of the disease by genotype in 18 pedigrees. Am J Clin Pathol. 78:1982;196-207.
10. Bassett ML, Halliday JW, Ferris RA, Powell LW. Diagnosis of hemochromatosis in young subjects: predictive accuracy of biochemical screening tests. Gastroenterology. 87:1984;628-633.
11. Bonkovsky HL, Slaker DP, Bills EB, Wolf DC. Usefulness and limitations of laboratory and hepatic imaging studies in iron-storage disease. Gastroenterology. 99:1990;1079-1091.
12. Edwards CQ, Kushner JP. Screening for hemochromatosis. N Engl J Med. 328:1993;1616-1620.
13. Bassett ML, Halliday JW, Powell LW. Value of hepatic iron measurements in early hemochromatosis and determination of the critical iron level associated with fibrosis. Hepatology. 6:1986;24-29.
14. Summers KM, Halliday JW, Powell LW. Identification of homozygous hemochromatosis subjects by measurement of hepatic iron index. Hepatology. 12:1990;20-25.
15. Sallie RW, Reed WD, Shilkin KB. Confirmation of the efficacy of hepatic tissue iron index in differentiating genetic haemochromatosis from alcoholic liver disease complicated by alcoholic haemosiderosis. Gut. 32:1991;207-210.
16. Di Bisceglie AM, Axiotis CA, Hoofnagle JH, Bacon BR. Measurements of iron status in patients with chronic hepatitis. Gastroenterology. 102:1992;2108-2113.
17. Chapman RW, Morgan MY, Laulicht M, Hoffbrand AV, Sherlock S. Hepatic iron stores and markers of iron overload in alcoholics and patients with idiopathic hemochromatosis. Dig Dis Sci. 27:1982;909-916.
18. Arber N, Konikoff FM, Moshkowitz M, Baratz M, Hallak A, Santo M, et al. Increased serum iron and iron saturation without liver iron accumulation distinguish chronic hepatitis C from other chronic liver diseases. Dig Dis Sci. 39:1994;2656-2659.
19. Bronner MP, Kowdley KV, Carlson TH, Lin M, Labbe RF. Intra-organ variability of hepatic iron concentration (HIC) with hepatitis C [abstract]. Hepatology. 22:1995;276.
20. Villeneuve JP, Bilodeau M, Lepage R, Cote J, Lefebvre M. Variability in hepatic iron concentration measurements from needle-biopsy specimens. J Hepatol. 25:1996;172-177.
21. Ludwig J, Hashimoto E, Porayko MK, Moyer TP, Baldus WP. Hemosiderosis in cirrhosis: a study of 447 native livers. Gastroenterology. 112:1997;882-888.
22. Deugnier Y, Turlin B, Quilleuc DL, Moirand R, Loreal O, Messner M, et al. A reappraisal of hepatic siderosis in patients with end-stage cirrhosis: practical implications for the diagnosis of hemochromatosis. Am J Surg Pathol. 21:1997;669-675.
23. Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A, et al. A novel MHC class 1-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet. 13:1996;399-408.
24. Beutler E, Gelbart T, West C, Lee P, Adams M, Blackstone R, et al. Mutation analysis in hereditary hemochromatosis. Blood Cells Mol Dis. 22:1996;187-194.
25. Jazwinska EC, Cullen LM, Busfield F, Pyper WR, Webb SI, Powell LW, et al. Haemochromatosis and HLA-H. Nat Genet. 14:1996;249-251.
26. Jouanolle AM, Gandon G, Jezequel P, Blayau M, Campion ML, Yaouang J, et al. Haemochromatosis and HLA-H. Nat Genet. 14:1996;251-252.
27. Carella M, D'Ambrosio L, Totaro A, Grifa A, Valentino MA, Piperno A, et al. Mutation analysis of the HLA-H gene in Italian hemochromatosis patients. Am J Hum Genet. 60:1997;828-832.
28. Santos M, Schilham MW, Rademakers LHPM, Marx JJM, de Sousa M, Clevers H. Defective iron homeostasis in B2-microglobulin knockout mice recapitulates hereditary hemochromatosis in man. J Exp Med. 184:1996;1975-1985.
29. Smith FE, herbert J, Gaudin J, Hennessy DJ, Reid GR. Serum iron determination using ferene triazine. Clin Biochem. 17:1984;306-310.
30. Giegel JL, Brotherton MM, Cronin P. Radial partition immunoassay. Clin Chem. 28:1982;1894-1898.
31. Searle JW, Kerr JFR, Halliday JW, Powell LW. Iron storage disease. MacSween RNM, Anthony PP, Scheuer PJ. 3rd ed. Pathology of the Liver. 1994;Churchill Livingstone, Edinburgh.
32. Frank TS, Svoboda-Newman SM, Hsi ED. Comparison of methods for extracting DNA from formalin-fixed paraffin sections for nonisotopic PCR. Diagn Mol Pathol. 5:1996;220-224.
33. Simon M, Mignon LL, Fauchet R, Yaouanq J, David V, Edan G, et al. A study of 609 HLA haplotypes marking for the hemochromatosis gene: (1) mapping of the gene near the HLA-A locus and characters required to define a heterozygous population and (2) hypothesis concerning the underlying cause of hemochromatosis-HLA association. Am J Hum Genet. 41:1987;89-105.
34. Adams PC, Bradley C, Frei JV. Hepatic iron and zinc concentrations after portacaval shunting for nonalcoholic cirrhosis. Hepatology. 19:1994;101-105.
35. Brissot P, Wright TL, Ma WL, Weisiger RA. Efficient clearance of non-transferrin-bound iron by rat liver: implications for hepatic iron loading in iron overload states. J Clin Invest. 76:1985;1463-1470.
36. Duane P, Raja KB, Simpson RJ, Peters TJ. Intestinal iron absorption in chronic alcoholics. Alcohol Alcohol. 27:1992;539-544.